Repairing resistance

Why Novo Holdings launched fund to invest in antimicrobial resistance plays

While Novo Nordisk Foundation has funded antimicrobial resistance research for years, the foundation’s investment arm, Novo Holdings A/S, is taking that mandate a step further with its first fund dedicated to early stage venture in the space.

On Wednesday, Novo Holdings’

Read the full 411 word article

User Sign In